<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7232622\results\search\disease\results.xml">
  <result pre="YorkUSA[6], Department of BiostatisticsIndiana University School of MedicineIndianapolisIndianaUSA[7], Centre for" exact="Infectious" post="Disease Epidemiology and Research, School of Public Health and"/>
  <result pre="Department of BiostatisticsIndiana University School of MedicineIndianapolisIndianaUSA[7], Centre for Infectious" exact="Disease" post="Epidemiology and Research, School of Public Health and Family"/>
  <result pre="infants exposed to HIV or ART in utero or via" exact="breast" post="milk. Participants IeDEA is organised in four regions (Central,"/>
  <result pre="and US universities, and almost 1.4 million children, adolescents and" exact="adult" post="people living with HIV (PLWHIV) enrolled. Findings to date"/>
  <result pre="loss to follow-up. We examined the impact of coinfection with" exact="hepatitis" post="B and C, and the epidemiology of different cancers"/>
  <result pre="the epidemiology of different cancers and of (multidrug resistant) tuberculosis," exact="renal disease" post="and of mental illness. The adoption of â€˜Treat Allâ€™,"/>
  <result pre="epidemiology of different cancers and of (multidrug resistant) tuberculosis, renal" exact="disease" post="and of mental illness. The adoption of â€˜Treat Allâ€™,"/>
  <result pre="cancers and of (multidrug resistant) tuberculosis, renal disease and of" exact="mental illness." post="The adoption of â€˜Treat Allâ€™, making ART available to"/>
  <result pre="to create a drug resistance database. HIV &amp;amp; AIDS epidemiology" exact="infectious diseases" post="tuberculosis Funding http://dx.doi.org/10.13039/100000061Fogarty International Center U01AI096299, U01AI069911, U01AI069924, U01AI069919"/>
  <result pre="a drug resistance database. HIV &amp;amp; AIDS epidemiology infectious diseases" exact="tuberculosis" post="Funding http://dx.doi.org/10.13039/100000061Fogarty International Center U01AI096299, U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000025National"/>
  <result pre="Health U01AI096299, U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000060National Institute of Allergy and" exact="Infectious" post="Diseases R24AI124872, U01AI096299, U01AI069911, U01AI069924 http://dx.doi.org/10.13039/100009633Eunice Kennedy Shriver National"/>
  <result pre="U01AI096299, U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000060National Institute of Allergy and Infectious" exact="Diseases" post="R24AI124872, U01AI096299, U01AI069911, U01AI069924 http://dx.doi.org/10.13039/100009633Eunice Kennedy Shriver National Institute"/>
  <result pre="U01AI069919 http://dx.doi.org/10.13039/501100001711Schweizerischer Nationalfonds zur FÃ¶rderung der Wissenschaftlichen Forschung 174281 http://dx.doi.org/10.13039/100000054National" exact="Cancer" post="Institute U01AI096299, U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000062National Institute of Diabetes"/>
  <result pre="http://dx.doi.org/10.13039/100000054National Cancer Institute U01AI096299, U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000062National Institute of" exact="Diabetes" post="and Digestive and Kidney Diseases U01AI096299, U01AI069911, U01AI069924, U01AI069919"/>
  <result pre="U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000062National Institute of Diabetes and Digestive and" exact="Kidney" post="Diseases U01AI096299, U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000027National Institute on Alcohol"/>
  <result pre="U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000062National Institute of Diabetes and Digestive and Kidney" exact="Diseases" post="U01AI096299, U01AI069911, U01AI069924, U01AI069919 http://dx.doi.org/10.13039/100000027National Institute on Alcohol Abuse"/>
  <result pre="of antiretroviral therapy (ART) in children, adolescents and pregnant and" exact="postpartum" post="women, across diverse settings. The data reflect routine care"/>
  <result pre="data quality, and data have been enriched by linkage to" exact="cancer" post="registries, vital registries and administrative databases. Collaborations with the"/>
  <result pre="and other consortia have ensured that the analyses of the" exact="African" post="IeDEA regions contributed to global health policy and decision-making."/>
  <result pre="health policy and decision-making. Weaknesses include the limitations inherent in" exact="secondary" post="use of routine clinical care data, with missing data,"/>
  <result pre="the incidence of new HIV-1 infections.2 However, in many settings," exact="HIV/AIDS" post="is still a public health threat. An estimated 1.8"/>
  <result pre="still a public health threat. An estimated 1.8 million new" exact="infections" post="occurred in 2017 and almost a million adult and"/>
  <result pre="million new infections occurred in 2017 and almost a million" exact="adult" post="and child deaths were due to HIV, most of"/>
  <result pre="HIV, most of them in sub-Saharan Africa.2 The WHO, the" exact="Joint" post="United Nations Programme on HIV/AIDS (UNAIDS) and many of"/>
  <result pre="sub-Saharan Africa.2 The WHO, the Joint United Nations Programme on" exact="HIV/AIDS" post="(UNAIDS) and many of the countries most heavily affected"/>
  <result pre="heavily affected by the HIV epidemic have committed to ending" exact="HIV/AIDS" post="as a major public health problem by 2030.1 Targets"/>
  <result pre="initiate ART and 90% of those on ART achieve undetectable" exact="viral" post="loads (the 90-90-90 targets).3 Progress towards these goals has"/>
  <result pre="substantial in Eastern and Southern Africa than in West and" exact="Central" post="Africa. Of the 20.6 million PLWHIV in Eastern and"/>
  <result pre="suppressed, compared with 39% of 5.0 million in West and" exact="Central" post="Africa.4 Established more than 10 years ago by the"/>
  <result pre="evaluate AIDS (IeDEA) are a global cohort collaboration that collects" exact="HIV/AIDS" post="data from HIV care and treatment programmes, including in"/>
  <result pre="Cohort description In 2006, the National Institute of Allergy and" exact="Infectious" post="Diseases sought applications for a global consortium structured through"/>
  <result pre="description In 2006, the National Institute of Allergy and Infectious" exact="Diseases" post="sought applications for a global consortium structured through regional"/>
  <result pre="the Asia-Pacific and four regions in sub-Saharan Africa: West Africa," exact="Central" post="Africa, East Africa and Southern Africa. The project was"/>
  <result pre="2021. Settings and number of PLWHIV enrolled To date, the" exact="African" post="regions of IeDEA received data from 240 HIV care"/>
  <result pre="from 240 HIV care and treatment facilities in 19 sub-Saharan" exact="African" post="countries (figure 1A). Close to 1 400 000 PLWHIV"/>
  <result pre="both urban and rural facilities are well represented, while in" exact="Central" post="and West Africa, urban facilities dominate. Facilities are predominately"/>
  <result pre="dominate. Facilities are predominately public (94%) and operated at the" exact="primary" post="or secondary care level, with the exception of West"/>
  <result pre="are predominately public (94%) and operated at the primary or" exact="secondary" post="care level, with the exception of West Africa where"/>
  <result pre="Map of the 240 active facilities participating in the four" exact="African" post="regions of the International epidemiology Databases to Evaluate AIDS"/>
  <result pre="Table 1 Characteristics of 240 facilities providing ART in the" exact="African" post="regions of the IeDEA (source: site assessment survey 2017"/>
  <result pre="site assessment survey 2017 and IeDEA database 2019) West Africa" exact="Central" post="Africa East Africa Southern Africa All regions (%) No."/>
  <result pre="4 12 (5) â€ƒMissing 3 0 0 0 3 (1)" exact="Viral" post="load â€ƒRoutine testing 12 16 46 74 148 (62)"/>
  <result pre="protocol (see www.iedeades.org) with 25 data tables, which include a" exact="total" post="of 228 unique variables (36 compulsory and 192 additional"/>
  <result pre="treatment, for dropping out of the cohort, for mode of" exact="HIV infection," post="country, type and site of comorbidities, laboratory measurements and"/>
  <result pre="comorbidities, laboratory measurements and units of measurements and type of" exact="viral" post="load assay. The collection, management and sharing of data"/>
  <result pre="For example, a study compared the characteristics and comprehensiveness of" exact="adult" post="HIV care and treatment programmes in sub-Saharan Africa with"/>
  <result pre="disorders,8 or the diagnostic and screening practices for (drug resistant)" exact="tuberculosis" post="in adult and paediatric patients.9â€&quot;11 Furthermore, the routine data"/>
  <result pre="the diagnostic and screening practices for (drug resistant) tuberculosis in" exact="adult" post="and paediatric patients.9â€&quot;11 Furthermore, the routine data collected by"/>
  <result pre="enriched in some countries by linking the HIV databases to" exact="cancer" post="registries,12 13 vital registries14 or administrative databases.15 Trends in"/>
  <result pre="registries14 or administrative databases.15 Trends in CD4 cell count and" exact="viral" post="load measurements While WHO continues to recommend a CD4"/>
  <result pre="count before starting ART to inform the management of advanced" exact="disease" post="and differentiated care in the Treat All era, it"/>
  <result pre="era, it also recommends that CD4 testing be replaced by" exact="viral" post="load measurement for monitoring of treatment and identification of"/>
  <result pre="West Africa, the number of CD4 measurements tended to be" exact="stable" post="over time, despite an increasing number of PLWHIV in"/>
  <result pre="increasing number of PLWHIV in care, while in East and" exact="Central" post="Africa, the number of CD4 measurements dropped. At present,"/>
  <result pre="the active facilities reported routine CD4 testing and 62% routine" exact="viral" post="load testing (table 1). The US Presidentâ€™s Emergency Plan"/>
  <result pre="testing.17 Figure 2 Daily number of CD4 cell counts and" exact="viral" post="load (VL) measurements over time (bar chart) and the"/>
  <result pre="phasing out of stavudine (D4T) and nevirapine (NVP) was almost" exact="complete" post="in 2014 (table 2). East Africa and Southern Africa"/>
  <result pre="resistance.18 19 Due to concerns about an increased risk of" exact="neural tube defects" post="if taken during pregnancy,20 the roll-out to women has"/>
  <result pre="during pregnancy,20 the roll-out to women has been delayed or" exact="limited" post="in some settings. Of note, drug stock-outs in the"/>
  <result pre="of first-line antiretroviral therapy, by time period and region â€ƒ" exact="Central" post="Africa East Africa 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012"/>
  <result pre="to 2016, mortality at 3 years declined substantially in all" exact="African" post="IeDEA regions (figure 3A). Loss to follow-up, defined as"/>
  <result pre="a core grant from the NIH to one or several" exact="African" post="IeDEA regions, and these publications have been cited over"/>
  <result pre="(iii) hepatitis, (iv) mental health, (v) motherâ€&quot;infant and paediatrics, (vi)" exact="renal disease," post="(vii) substance use and (viii) tuberculosis. Multiregional research concepts"/>
  <result pre="UNAIDS.21â€&quot;23 The number of publications reporting multiregional analyses from several" exact="African" post="IeDEA regions increased over time, from one such publication"/>
  <result pre="and virological response to different ART regimens.24â€&quot;37 For example, the" exact="African" post="IeDEA regions contributed importantly to a large-scale analysis of"/>
  <result pre="a large-scale analysis of outcomes in adolescents living with perinatally" exact="acquired" post="HIV, which showed that HIV-associated mortality during adolescence was"/>
  <result pre="loss to follow-up.40â€&quot;46 For example, an analysis of all four" exact="African" post="regions showed that when analysing the uncorrected data observed"/>
  <result pre="investigators have examined the prevalence and impact of coinfection with" exact="hepatitis" post="B and C, and the epidemiology of different cancers"/>
  <result pre="the epidemiology of different cancers and of (multidrug resistant) tuberculosis," exact="renal disease" post="and of mental illness.8 47â€&quot;58 For example, an analysis"/>
  <result pre="epidemiology of different cancers and of (multidrug resistant) tuberculosis, renal" exact="disease" post="and of mental illness.8 47â€&quot;58 For example, an analysis"/>
  <result pre="from Europe or Asia had a high risk of developing" exact="Kaposi sarcoma" post="after starting ART.58 Similarly, a recent analysis of IeDEA"/>
  <result pre="Europe or Asia had a high risk of developing Kaposi" exact="sarcoma" post="after starting ART.58 Similarly, a recent analysis of IeDEA"/>
  <result pre="COHERE data showed that compared with European women, rates of" exact="cervical cancer" post="were 11 times higher in South Africa.50 A recent"/>
  <result pre="data showed that compared with European women, rates of cervical" exact="cancer" post="were 11 times higher in South Africa.50 A recent"/>
  <result pre="in South Africa.50 A recent multiregional study of multidrug resistant" exact="tuberculosis" post="included HIV-positive and HIV-negative adults with tuberculosis from seven"/>
  <result pre="Africa.50 A recent multiregional study of multidrug resistant tuberculosis included" exact="HIV-positive" post="and HIV-negative adults with tuberculosis from seven high-burden countries"/>
  <result pre="of multidrug resistant tuberculosis included HIV-positive and HIV-negative adults with" exact="tuberculosis" post="from seven high-burden countries (CÃ´te d'Ivoire, Democratic Republic of"/>
  <result pre="inaccurate local drug susceptibility testing led to undertreatment of drug-resistant" exact="tuberculosis" post="and increased mortality.54 Challenge of â€˜Treat Allâ€™ Nearly all"/>
  <result pre="the â€˜Treat Allâ€™ policy in children and adolescents,63 pregnant and" exact="postpartum" post="women,64 and for mental health, substance use65 and drug"/>
  <result pre="in selected IeDEA sites on cardiometabolic risk factors (eg, hypertension," exact="diabetes" post="and dyslipidaemia) liver disease (liver fibrosis and steatosis), mental"/>
  <result pre="sites on cardiometabolic risk factors (eg, hypertension, diabetes and dyslipidaemia)" exact="liver disease" post="(liver fibrosis and steatosis), mental health and substance use."/>
  <result pre="on cardiometabolic risk factors (eg, hypertension, diabetes and dyslipidaemia) liver" exact="disease" post="(liver fibrosis and steatosis), mental health and substance use."/>
  <result pre="mental health and substance use. In the East and Southern" exact="African" post="regions, pharmacovigilance in pregnancy is being developed to assess"/>
  <result pre="of ART on birth outcomes. A project involving all four" exact="African" post="regions studies the cascade of screening for cervical cancer,"/>
  <result pre="all four African regions studies the cascade of screening for" exact="cervical cancer," post="while the establishment of the South African HIV Cancer"/>
  <result pre="screening for cervical cancer, while the establishment of the South" exact="African" post="HIV Cancer Match (SAM) study of over 10 million"/>
  <result pre="cervical cancer, while the establishment of the South African HIV" exact="Cancer" post="Match (SAM) study of over 10 million PLWHIV, from"/>
  <result pre="over 10 million PLWHIV, from linkage of national laboratory with" exact="cancer" post="registry data, will allow the study of less common"/>
  <result pre="in routine clinical care is another planned addition. Collaborations The" exact="African" post="regions of IeDEA have collaborated and continue to encourage"/>
  <result pre="US National Institutes of Health's National Institute of Allergy and" exact="Infectious" post="Diseases, the Eunice Kennedy Shriver National Institute of Child"/>
  <result pre="National Institute of Child Health and Human Development, the National" exact="Cancer" post="Institute, the National Institute of Mental Health, the National"/>
  <result pre="Institute on Drug Abuse and Alcoholism, the National Institute of" exact="Diabetes" post="and Digestive and Kidney Diseases, the Fogarty International Center,"/>
  <result pre="and Alcoholism, the National Institute of Diabetes and Digestive and" exact="Kidney" post="Diseases, the Fogarty International Center, the National Library of"/>
  <result pre="National Library of Medicine and the Office of the Director:" exact="Central" post="Africa, U01AI096299; East Africa, U01AI069911; Southern Africa, U01AI069924; West"/>
  <result pre="Inform2019;95:103208. 10.1016/j.jbi.2019.10320831078660 7DudaSN, FarrAM, LindegrenML, et al.Characteristics and comprehensiveness of" exact="adult" post="HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa"/>
  <result pre="10.1002/jia2.2510129603887 9BallifM, NhanduV, WoodR, et al.Detection and management of drug-resistant" exact="tuberculosis" post="in HIV-infected patients in lower-income countries. Int J Tuberc"/>
  <result pre="in low- and middle-income countries: diagnosis and screening practices. J" exact="Pediatric" post="Infect Dis Soc2015;4:30â€&quot;8. 10.1093/jpids/piu02026407355 12HornerM-J, ChasimphaS, SpoerriA, et al.High"/>
  <result pre="Pediatric Infect Dis Soc2015;4:30â€&quot;8. 10.1093/jpids/piu02026407355 12HornerM-J, ChasimphaS, SpoerriA, et al.High" exact="cancer" post="burden among antiretroviral therapy users in Malawi: a record"/>
  <result pre="users in Malawi: a record linkage study of observational human" exact="immunodeficiency" post="virus cohorts and cancer registry data. Clin Infect Dis."/>
  <result pre="record linkage study of observational human immunodeficiency virus cohorts and" exact="cancer" post="registry data. Clin Infect Dis. 13DhokoteraT, BohliusJ, SpoerriA, et"/>
  <result pre="al.The burden of cancers associated with HIV in the South" exact="African" post="public health sector, 2004-2014: a record linkage study. Infect"/>
  <result pre="10.1186/s13027-019-0228-731073325 14BoulleA, SchomakerM, MayMT, et al.Mortality in patients with HIV-1" exact="infection" post="starting antiretroviral therapy in South Africa, Europe, or North"/>
  <result pre="J Virus Erad2018;4:9â€&quot;15.30515309 22AndereggN, JohnsonLF, ZaniewskiE, et al.All-Cause mortality in" exact="HIV-positive" post="adults starting combination antiretroviral therapy: correcting for loss to"/>
  <result pre="10.1097/QAD.000000000000130628301337 24DaviesM-A, MayM, Bolton-MooreC, et al.Prognosis of children with HIV-1" exact="infection" post="starting antiretroviral therapy in southern Africa. Pediatr Infect Dis"/>
  <result pre="BalestreE, et al.Monitoring and switching of first-line antiretroviral therapy in" exact="adult" post="treatment cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV2015;2:e271â€&quot;8."/>
  <result pre="32KiraggaAN, LokJJ, MusickBS, et al.Cd4 trajectory adjusting for dropout among" exact="HIV-positive" post="patients receiving combination antiretroviral therapy in an East African"/>
  <result pre="among HIV-positive patients receiving combination antiretroviral therapy in an East" exact="African" post="HIV care centre. J Int AIDS Soc2014;17:18957. 10.7448/IAS.17.1.1895725131801 33GengEH,"/>
  <result pre="children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South" exact="African" post="multi-cohort analysis. Pediatr Infect Dis J2014;33:617â€&quot;22. 10.1097/INF.000000000000022224378944 35TenthaniL, HaasAD,"/>
  <result pre="SlogroveAL, SchomakerM, et al.The epidemiology of adolescents living with perinatally" exact="acquired" post="HIV: a cross-region global cohort analysis. PLoS Med2018;15:e1002514. 10.1371/journal.pmed.100251429494593"/>
  <result pre="PLoS Med2011;8:e1000390. 10.1371/journal.pmed.100039021267057 45YiannoutsosCT, JohnsonLF, BoulleA, et al.Estimated mortality of" exact="adult" post="HIV-infected patients starting treatment with combination antiretroviral therapy. Sex"/>
  <result pre="AIDS Soc2018;21:e25084. 10.1002/jia2.25084 47HectorJ, VinikoorM, ChilengiR, et al.No impact of" exact="hepatitis" post="B virus infection on early mortality among human immunodeficiency"/>
  <result pre="10.1002/jia2.25084 47HectorJ, VinikoorM, ChilengiR, et al.No impact of hepatitis B" exact="virus infection" post="on early mortality among human immunodeficiency virus-infected patients in"/>
  <result pre="47HectorJ, VinikoorM, ChilengiR, et al.No impact of hepatitis B virus" exact="infection" post="on early mortality among human immunodeficiency virus-infected patients in"/>
  <result pre="of hepatitis B virus infection on early mortality among human" exact="immunodeficiency" post="virus-infected patients in southern Africa. Clin Infect Dis2018;67:1310â€&quot;1. 10.1093/cid/ciy30429912371"/>
  <result pre="Infect Dis2018;67:1310â€&quot;1. 10.1093/cid/ciy30429912371 48WandelerG, MulengaL, HobbinsM, et al.Absence of active" exact="hepatitis C" post="virus infection in human immunodeficiency virus clinics in Zambia"/>
  <result pre="10.1093/cid/ciy30429912371 48WandelerG, MulengaL, HobbinsM, et al.Absence of active hepatitis C" exact="virus infection" post="in human immunodeficiency virus clinics in Zambia and Mozambique."/>
  <result pre="48WandelerG, MulengaL, HobbinsM, et al.Absence of active hepatitis C virus" exact="infection" post="in human immunodeficiency virus clinics in Zambia and Mozambique."/>
  <result pre="et al.Absence of active hepatitis C virus infection in human" exact="immunodeficiency" post="virus clinics in Zambia and Mozambique. Open Forum Infect"/>
  <result pre="Forum Infect Dis2016;3:ofw049. 10.1093/ofid/ofw04927047986 49JaquetA, WandelerG, NouamanM, et al.Alcohol use," exact="viral hepatitis" post="and liver fibrosis among HIV-positive persons in West Africa:"/>
  <result pre="Infect Dis2016;3:ofw049. 10.1093/ofid/ofw04927047986 49JaquetA, WandelerG, NouamanM, et al.Alcohol use, viral" exact="hepatitis" post="and liver fibrosis among HIV-positive persons in West Africa:"/>
  <result pre="10.1093/ofid/ofw04927047986 49JaquetA, WandelerG, NouamanM, et al.Alcohol use, viral hepatitis and" exact="liver fibrosis" post="among HIV-positive persons in West Africa: a cross-sectional study."/>
  <result pre="NouamanM, et al.Alcohol use, viral hepatitis and liver fibrosis among" exact="HIV-positive" post="persons in West Africa: a cross-sectional study. J Int"/>
  <result pre="J Int AIDS Soc2017;19:21424. 10.7448/IAS.20.1.2142428362065 50RohnerE, BÃ¼tikoferL, SchmidlinK, et al.Cervical" exact="cancer" post="risk in women living with HIV across four continents:"/>
  <result pre="J Cancer2020;146:601â€&quot;9. 10.1002/ijc.3226031215037 51BrownSA, AbbasS, DaviesM-A, et al.Brief report: pediatric" exact="cancer" post="burden and treatment resources within the pediatric IeDEA Consortium."/>
  <result pre="Syndr2017;76:60â€&quot;4. 10.1097/QAI.000000000000145328520616 52SemeereA, WengerM, BusakhalaN, et al.A prospective ascertainment of" exact="cancer" post="incidence in sub-Saharan Africa: the case of Kaposi sarcoma."/>
  <result pre="ascertainment of cancer incidence in sub-Saharan Africa: the case of" exact="Kaposi sarcoma." post="Cancer Med2016;5:914â€&quot;28. 10.1002/cam4.61826823008 53CarlucciJG, Blevins PeratikosM, KippAM, et al.Tuberculosis"/>
  <result pre="cancer incidence in sub-Saharan Africa: the case of Kaposi sarcoma." exact="Cancer" post="Med2016;5:914â€&quot;28. 10.1002/cam4.61826823008 53CarlucciJG, Blevins PeratikosM, KippAM, et al.Tuberculosis treatment"/>
  <result pre="et al.Drug susceptibility testing and mortality in patients treated for" exact="tuberculosis" post="in high-burden countries: a multicentre cohort study. Lancet Infect"/>
  <result pre="Dis2019;19:298â€&quot;307. 10.1016/S1473-3099(18)30673-X30744962 55GygliSM, KellerPM, BallifM, et al.Whole-Genome Sequencing for Drug" exact="Resistance" post="Profile Prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother2019;63:e02175â€&quot;18. 10.1128/AAC.02175-1830718257"/>
  <result pre="10.1128/AAC.02175-1830718257 56ZÃ¼rcherK, BallifM, KiertiburanakulS, et al.Diagnosis and clinical outcomes of" exact="extrapulmonary tuberculosis" post="in antiretroviral therapy programmes in low- and middle-income countries:"/>
  <result pre="56ZÃ¼rcherK, BallifM, KiertiburanakulS, et al.Diagnosis and clinical outcomes of extrapulmonary" exact="tuberculosis" post="in antiretroviral therapy programmes in low- and middle-income countries:"/>
  <result pre="therapy outcomes in Zambia. Clin Infect Dis2014;58:1473â€&quot;80. 10.1093/cid/ciu11724585558 58et alcollab:" exact="Pediatric" post="AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa,"/>
  <result pre="in Zambia. Clin Infect Dis2014;58:1473â€&quot;80. 10.1093/cid/ciu11724585558 58et alcollab: Pediatric AIDS-Defining" exact="Cancer" post="Project Working Group for IeDEA Southern Africa, TApHOD, and"/>
  <result pre="Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoordKaposi" exact="sarcoma" post="risk in HIV-infected children and adolescents on combination antiretroviral"/>
  <result pre="initiation after national &quot;treat all&quot; policy adoption in 6 sub-Saharan" exact="African" post="countries: Regression discontinuity analysis. PLoS Med2019;16:e1002822. 10.1371/journal.pmed.100282231181056 61YotebiengM, BrazierE,"/>
  <result pre="HumphreyJM, MpodyC, et al.Achieving UNAIDS 90-90-90 targets for pregnant and" exact="postpartum" post="women in sub-Saharan Africa: progress, gaps and research needs."/>
  <result pre="al.Global temporal changes in the proportion of children with advanced" exact="disease" post="at the start of combination antiretroviral therapy in an"/>
 </snippets>
</snippetsTree>
